Nikulski Financial Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,832 shares of the healthcare conglomerate’s stock after acquiring an additional 408 shares during the period. UnitedHealth Group accounts for approximately 1.8% of Nikulski Financial Inc.’s portfolio, making the stock its 16th biggest position. Nikulski Financial Inc.’s holdings in UnitedHealth Group were worth $5,985,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the company. Dark Forest Capital Management LP raised its position in shares of UnitedHealth Group by 76.9% during the 2nd quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock valued at $374,000 after buying an additional 319 shares during the period. Scientech Research LLC purchased a new stake in UnitedHealth Group in the second quarter valued at $1,071,000. Sepio Capital LP grew its holdings in shares of UnitedHealth Group by 0.3% during the 2nd quarter. Sepio Capital LP now owns 5,822 shares of the healthcare conglomerate’s stock worth $2,965,000 after purchasing an additional 20 shares during the period. Texas Capital Bank Wealth Management Services Inc lifted its position in UnitedHealth Group by 6.6% in the second quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,134 shares of the healthcare conglomerate’s stock valued at $8,216,000 after buying an additional 994 shares during the last quarter. Finally, Kathmere Capital Management LLC increased its position in shares of UnitedHealth Group by 25.1% during the second quarter. Kathmere Capital Management LLC now owns 4,768 shares of the healthcare conglomerate’s stock valued at $2,428,000 after acquiring an additional 958 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Trading Up 0.5 %
NYSE:UNH opened at $532.26 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock’s 50 day moving average price is $541.04 and its 200 day moving average price is $563.84. The company has a market capitalization of $489.83 billion, a PE ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.58%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.19%.
Insider Buying and Selling
In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.33% of the company’s stock.
Analyst Upgrades and Downgrades
UNH has been the subject of several research reports. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $627.74.
Read Our Latest Analysis on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- 10 Best Airline Stocks to Buy
- Bloom Energy: Powering the Future With Decentralized Energy
- Investing In Automotive Stocks
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.